BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25009596)

  • 1. PPM1D is a prognostic marker and therapeutic target in colorectal cancer.
    Peng TS; He YH; Nie T; Hu XD; Lu HY; Yi J; Shuai YF; Luo M
    Exp Ther Med; 2014 Aug; 8(2):430-434. PubMed ID: 25009596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPM1D as a novel biomarker for prostate cancer after radical prostatectomy.
    Jiao L; Shen D; Liu G; Jia J; Geng J; Wang H; Sun Y
    Anticancer Res; 2014 Jun; 34(6):2919-25. PubMed ID: 24922655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of PPM1D in 800 gastric cancer patients.
    Ma D; Zhang CJ; Chen ZL; Yang H
    Mol Med Rep; 2014 Jul; 10(1):191-4. PubMed ID: 24788664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein phosphatase magnesium-dependent 1δ (PPM1D) mRNA expression is a prognosis marker for hepatocellular carcinoma.
    Li GB; Zhang XL; Yuan L; Jiao QQ; Liu DJ; Liu J
    PLoS One; 2013; 8(3):e60775. PubMed ID: 23556002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Phosphatase Magnesium-Dependent 1δ (PPM1D) Expression as a Prognostic Marker in Adult Supratentorial Diffuse Astrocytic and Oligodendroglial Tumors.
    Jeong HJ; Woo CG; Lee B; Khang SK; Nam SJ; Choi J
    J Pathol Transl Med; 2018 Mar; 52(2):71-78. PubMed ID: 29046514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
    Gao JY; Song BR; Peng JJ; Lu YM
    World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal expression of calcyphosine is associated with poor prognosis and cell biology function in colorectal cancer.
    Shao W; Wang Q; Wang F; Jiang Y; Xu M; Xu J
    Onco Targets Ther; 2016; 9():477-87. PubMed ID: 26889086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
    Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
    Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPM1D Functions as Oncogene and is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma.
    Li K; Liu Y; Xu S; Wang J
    Pathol Oncol Res; 2020 Jan; 26(1):387-395. PubMed ID: 30374621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
    Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
    Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
    Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C
    PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer.
    Ng TH; Sham KWY; Xie CM; Ng SSM; To KF; Tong JHM; Liu WYZ; Zhang L; Chan MTV; Wu WKK; Cheng CHK
    BMC Cancer; 2019 Jul; 19(1):649. PubMed ID: 31266475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
    Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
    Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
    Li X; Wang F; Sun Y; Fan Q; Cui G
    Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinical significance of absent in melanoma 2 in colorectal cancer.
    Zhang Z; Dong X; Yang X; Wan D; Sun L; Gu M; Li M; Zhu Z; Wang J; Shang Z; He S
    Biomed Pharmacother; 2017 Oct; 94():843-849. PubMed ID: 28802238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of protein phosphatase magnesium-dependent 1 (PPM1D) through lentivirus-mediated RNA silencing inhibits colorectal carcinoma cell proliferation.
    Yin H; Yan Z; Liang Y; Liu B; Su Q
    Technol Cancer Res Treat; 2013 Dec; 12(6):537-43. PubMed ID: 23745790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of DSCR1 prevents proliferation and predicts favorable prognosis in colorectal cancer patients.
    Li WX; Zheng JJ; Zhao G; Lyu CT; Lu WQ
    World J Surg Oncol; 2021 Apr; 19(1):100. PubMed ID: 33827593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of AKIP1 contributes to metastasis and progression and predicts poor prognosis of patients with colorectal cancer.
    Jiang W; Yang W; Yuan L; Liu F
    Onco Targets Ther; 2018; 11():6795-6801. PubMed ID: 30349312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway.
    Pan Y; Cheung ST; Tong JHM; Tin KY; Kang W; Lung RWM; Wu F; Li H; Ng SSM; Mak TWC; To KF; Chan AWH
    J Transl Med; 2018 Jun; 16(1):150. PubMed ID: 29866109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.